Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Back
Association details:
Biomarker:
No biomarker
Cancer:
Peritoneal Cancer
Drug:
exemestane
(
Aromatase inhibitor
)
Direction:
Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
NCCN
Excerpt:
Ovarian cancer/Fallopian Tube cancer/Primary Peritoneal cancer: Preferred Regimens...Hormone therapy (aromatase inhibitors: anastrozole, letrozole, exemestane) (category 2B).
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login